Stockscreener 앱 받기
5.0006
2.85%
-0.1294
전일 마감가:
$5.13
열려 있는:
$5.14
하루 거래량:
149.57K
Relative Volume:
0.26
시가총액:
$1.55B
수익:
$391.87M
순이익/손실:
$-441.45M
주가수익비율:
-2.703
EPS:
-1.85
순현금흐름:
$-301.21M
1주 성능:
-5.25%
1개월 성능:
+8.34%
6개월 성능:
-44.19%
1년 성능:
-62.13%
1일 변동 폭
$4.96
$5.14
1주일 범위
$4.96
$5.23
52주 변동 폭
$4.32
$13.70
Alvotech Stock (ALVO) Company Profile
ALVO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALVO
Alvotech
|
4.985 | 1.60B | 391.87M | -441.45M | -301.21M | -1.85 |
|
ZTS
Zoetis Inc
|
125.51 | 55.45B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.62 | 49.25B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.02 | 45.02B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.66 | 35.81B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
492.08 | 20.98B | 3.08B | 1.24B | 1.07B | 25.61 |
Alvotech Stock (ALVO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-11-04 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2025-10-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2025-09-23 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-02-14 | 개시 | UBS | Buy |
| 2024-01-29 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-10-20 | 업그레이드 | Citigroup | Sell → Neutral |
| 2023-09-21 | 개시 | Barclays | Equal Weight |
| 2022-09-07 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-09-06 | 다운그레이드 | Citigroup | Buy → Sell |
| 2022-07-26 | 개시 | Citigroup | Buy |
모두보기
Alvotech 주식(ALVO)의 최신 뉴스
Alvotech’s Volatile Ascent: Can A High?Beta Biosimilar Pure Play Keep Its Momentum? - AD HOC NEWS
Alvotech secures $100 million loan facility - Biostock
Icelandic BioTech Alvotech secures €100 million term loan facility to bolster liquidity and R&D investment - EU-Startups
What analysts say about Alvotech Z45 stockEarnings Forecast Updates & Double Digit Returns - earlytimes.in
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in US - MSN
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged ... - Bluefield Daily Telegraph
ALVO Investor News: If You Have Suffered Losses in Alvotech (NASDAQ: ALVO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Alvotech Secures USD 100 Million Senior Term Loan to Enhance Liquidity and Support R&D Initiatives - Quiver Quantitative
Alvotech Secures Term Loan Facility of USD 100 Million - The Manila Times
Alvotech (NASDAQ:ALVO) Trading 2.9% HigherShould You Buy? - MarketBeat
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - PR Newswire
Alvotech announced that it has received $100 million in funding - marketscreener.com
The Technical Signals Behind (ALVO) That Institutions Follow - Stock Traders Daily
ALVO Investor News: If You Have Suffered Losses in Alvotech - GlobeNewswire
Alvotech Files Notification with CSSF Regarding Changes in Own Shares - Quiver Quantitative
Changes in company's own shares - marketscreener.com
Alvotech : Changes in company's own shares - marketscreener.com
Alvotech : Acquisition or disposal of the issuer's own sharesALVOTECH - marketscreener.com
EV Market: Why Alvotech stock is favored by top institutionsMarket Sentiment Review & Growth Oriented Trading Recommendations - moha.gov.vn
Mereo BioPharma, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Why Bolt Projects Holdings Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket - Benzinga
Alvotech (NASDAQ:ALVO) Short Interest Down 41.1% in December - MarketBeat
Is Alvotech stock near bottom after declineSwing Trading Watchlist & Build Wealth Brick by Brick With Us - bollywoodhelpline.com
Alvotech Investor News: Rosen Law Firm Encourages Alvotech Inves - GuruFocus
Alvotech (NASDAQ:ALVO) Trading Up 6.8%Time to Buy? - MarketBeat
Alvotech (ALVO): Firm reaffirms 2025 growth outlook - MSN
Alvotech Begins European Rollout of First-Ever Simponi Biosimilar Gobivaz - TipRanks
Why Alvotech (ALVO) Is Down 8.5% After Securing a 2026 US Entry Window for AVT06 - simplywall.st
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma - Sahm
Alvotech announces European launch of biosimilar to Simponi - MSN
Alvotech/Advanz First to Launch Golimumab Biosimilar Worldwide - Pearce IP
Alvotech’s Financial Calendar for 2026 - The Manila Times
Alvotech : Financial Calendar for 2026 - marketscreener.com
Alvotech rolls out first Simponi biosimilar across Europe - The Pharma Letter
Alvotech Launching Gobivaz Biosimilar in Europe - marketscreener.com
New Simponi lookalike drug rolls out in Europe with NHS backing - Stock Titan
Alvotech Announces Launch of Gobivaz® (AVT05) in the UK Following NHS England Tender Award - Quiver Quantitative
Alvotech, Teva reach settlement and license agreement with Regeneron for AVT06 - MSN
Fund Flows: Is Alvotech stock supported by strong fundamentalsMarket Risk Analysis & Real-Time Volume Analysis Alerts - moha.gov.vn
Alvotech (ALVO): Firm Reaffirms 2025 Growth Outlook - Finviz
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Alvotech Investors to Inquire About Securities Class Action InvestigationALVO - ACCESS Newswire
Assessing Alvotech (NasdaqGM:ALVO)’s Valuation After FDA Setback and 2025 Guidance Cut - simplywall.st
Big Money Moves: Why retail investors favor Alvotech stockEarnings Miss & Short-Term Trading Opportunity Alerts - ulpravda.ru
Volume Recap: Why Alvotech Equity Warrant stock remains resilient2025 Market WrapUp & Long Hold Capital Preservation Tips - ulpravda.ru
Alvotech, Teva secure US settlement with Regeneron for Eylea biosimilar launch - Indian Pharma Post
Can Alvotech stock beat market expectations this quarterMarket Activity Recap & Capital Efficient Trading Techniques - ulpravda.ru
Is Alvotech stock gaining market shareJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - ulpravda.ru
Alvotech to raise $100M via convertible bonds, provides 2026 forecast - MSN
Alvotech price target lowered to $10 from $14 at Morgan Stanley - MSN
How interest rate cuts could boost Alvotech Equity Warrant stockQuarterly Trade Summary & Free Reliable Trade Execution Plans - ulpravda.ru
Can Alvotech stock sustain revenue growthRecession Risk & Stock Portfolio Risk Management - ulpravda.ru
Alvotech (ALVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.43%
1.70%
자본화:
|
볼륨(24시간):